Showing results (221-230 of 246) with videos related to

Sort By:
Pageof 25
Chemical Reviews|February 13, 2020
Nitrogen in DiamondMichael N R Ashfold, Jonathan P Goss, Ben L Green, et al.
Physical Review Letters|October 4, 2005
Importance of quantum tunneling in vacancy-hydrogen complexes in diamondM J Shaw, P R Briddon, J P Goss, et al.
Leukemia & Lymphoma|June 1, 1995
A phase II trial of prednisone, oral etoposide, and novantrone (PEN) as initial treatment of non-Hodgkin's lymphoma in elderly patientsP Goss, R Burkes, L Rudinskas, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 1, 1989
Kaposi's sarcoma and AIDS: a variable spectrumF A Shepherd, S Hogg-Johnson, N Fleshner, et al.
Developmental Biology|November 15, 2000
E2F1 and p53 are dispensable, whereas p21(Waf1/Cip1) cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesisZ Jiang, P Liang, R Leng, et al.
Chemical Communications (Cambridge, England)|May 14, 2009
Self-assembly of a bis(adeninyl)-Cu(I) complex: a cationic nucleobase duplex mimicMiguel A Galindo, David Amantia, William Clegg, et al.
Leukemia & Lymphoma|August 10, 1999
Combined results of two phase II studies of Taxol (paclitaxel) in patients with relapsed or refractory lymphomasP Goss, A K Stewart, F Couture, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 24, 2011
Anatomical distribution of vertebral fractures: comparison of pediatric and adult spinesK Siminoski, K-C Lee, H Jen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancerR Pérez Carrión, V Alberola Candel, F Calabresi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 2, 2008
Risk factors for low BMD in healthy men age 50 years or older: a systematic reviewA Papaioannou, C C Kennedy, A Cranney, et al.
Pageof 25